{"created":"2023-06-19T09:51:23.345909+00:00","id":8557,"links":{},"metadata":{"_buckets":{"deposit":"a61cc609-6176-4485-b987-356686c0f63c"},"_deposit":{"created_by":18,"id":"8557","owners":[18],"pid":{"revision_id":0,"type":"depid","value":"8557"},"status":"published"},"_oai":{"id":"oai:fukuyama-u.repo.nii.ac.jp:00008557","sets":["502:503:627:762"]},"author_link":["45165"],"item_10002_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2009-12-25","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"27","bibliographicPageEnd":"14","bibliographicPageStart":"1","bibliographic_titles":[{"bibliographic_title":"福山大学薬学部研究年報"},{"bibliographic_title":"Annual report of the Faculty of Pharmacy & Pharmaceutical Sciences, Fukuyama University","bibliographic_titleLang":"en"}]}]},"item_10002_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"ウイルス性肝炎の原因ウイルスとして、A型肝炎ウイルス、B型肝炎ウイルス、C型肝炎ウイルス、E型肝炎ウイルスを挙げ、急性肝炎および慢性肝炎の特徴と治療法について概説した。また、1990年代に新しく発見されたGBウイルスタイプC(GBV-C)の疫学的研究として以下について述べた。1)ALT値異常の献血者におけるGBV-C RNA陽性率。2)医療機関などからの依頼検体におけるGBV-C RNA陽性率。3)HLA適合血小板輸血を行っている患者におけるGBV-C RNA陽性率。4)GBV-C輸血後感染症が疑われる例についてのレトロスペクティブスタディ。","subitem_description_type":"Abstract"}]},"item_10002_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"福山大学薬学部"}]},"item_10002_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN10064550","subitem_source_identifier_type":"NCID"}]},"item_10002_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0288-724X","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"小嶋, 英二朗"}],"nameIdentifiers":[{"nameIdentifier":"45165","nameIdentifierScheme":"WEKO"},{"nameIdentifier":"9000249257655","nameIdentifierScheme":"CiNii ID","nameIdentifierURI":"http://ci.nii.ac.jp/nrid/9000249257655"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2016-12-05"}],"displaytype":"detail","filename":"1小嶋.pdf","filesize":[{"value":"927.9 kB"}],"format":"application/pdf","license_note":"Copyright (c) 2009 by Fukuyama University","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"ウイルス性肝炎とGBウイルスタイプC","url":"https://fukuyama-u.repo.nii.ac.jp/record/8557/files/1小嶋.pdf"},"version_id":"1fe4c161-ef15-41a2-b487-b2fdebf6845b"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Cysteine(治療的利用)","subitem_subject_scheme":"Other"},{"subitem_subject":"Glycine(治療的利用)","subitem_subject_scheme":"Other"},{"subitem_subject":"Glycyrrhetinic Acid(治療的利用,類似体・誘導体)","subitem_subject_scheme":"Other"},{"subitem_subject":"Interferons(治療的利用)","subitem_subject_scheme":"Other"},{"subitem_subject":"Polyethylene Glycols(治療的利用)","subitem_subject_scheme":"Other"},{"subitem_subject":"Ribavirin(治療的利用)","subitem_subject_scheme":"Other"},{"subitem_subject":"ウイルスRNA","subitem_subject_scheme":"Other"},{"subitem_subject":"Ursodeoxycholic Acid(治療的利用)","subitem_subject_scheme":"Other"},{"subitem_subject":"B型肝炎ウイルス","subitem_subject_scheme":"Other"},{"subitem_subject":"ヘパシウイルス","subitem_subject_scheme":"Other"},{"subitem_subject":"E型肝炎ウイルス","subitem_subject_scheme":"Other"},{"subitem_subject":"*肝炎-ウイルス性-ヒト(薬物療法,病因)","subitem_subject_scheme":"Other"},{"subitem_subject":"肝炎-慢性(薬物療法)","subitem_subject_scheme":"Other"},{"subitem_subject":"献血者","subitem_subject_scheme":"Other"},{"subitem_subject":"HLA抗原","subitem_subject_scheme":"Other"},{"subitem_subject":"配合製剤(治療的利用)","subitem_subject_scheme":"Other"},{"subitem_subject":"Lamivudine(治療的利用)","subitem_subject_scheme":"Other"},{"subitem_subject":"*GBウイルスC","subitem_subject_scheme":"Other"},{"subitem_subject":"ヒトA型肝炎ウイルス","subitem_subject_scheme":"Other"},{"subitem_subject":"血小板輸血(有害作用)","subitem_subject_scheme":"Other"},{"subitem_subject":"RT-PCR法","subitem_subject_scheme":"Other"},{"subitem_subject":"Entecavir(治療的利用)","subitem_subject_scheme":"Other"},{"subitem_subject":"Polyethylene Glycol-Interferons(治療的利用)","subitem_subject_scheme":"Other"},{"subitem_subject":"Stronger Neo-Minophagen C(治療的利用)","subitem_subject_scheme":"Other"},{"subitem_subject":"血液媒介感染","subitem_subject_scheme":"Other"},{"subitem_subject":"ヒト","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"ウイルス性肝炎とGBウイルスタイプC","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"ウイルス性肝炎とGBウイルスタイプC"},{"subitem_title":"Viral hepatitis and GB virus type C","subitem_title_language":"en"}]},"item_type_id":"10002","owner":"18","path":["762"],"pubdate":{"attribute_name":"公開日","attribute_value":"2016-12-05"},"publish_date":"2016-12-05","publish_status":"0","recid":"8557","relation_version_is_last":true,"title":["ウイルス性肝炎とGBウイルスタイプC"],"weko_creator_id":"18","weko_shared_id":-1},"updated":"2023-06-19T10:21:34.402658+00:00"}